Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cells. [electronic resource]
Producer: 19900130Description: 233-8 p. digitalISSN:- 0340-7004
- Antigen-Presenting Cells -- physiology
- Antigens, CD -- analysis
- Antigens, Differentiation, T-Lymphocyte -- analysis
- CD3 Complex
- CD4 Antigens -- analysis
- CD4-Positive T-Lymphocytes -- immunology
- Humans
- Interleukin-2 -- pharmacology
- Lymphocyte Activation
- Neoplasms -- immunology
- Phenotype
- Receptors, Antigen, T-Cell -- analysis
- T-Lymphocytes -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.